SCHEMBL19973435

SCHEMBL19973435

CN1CCC(NC(=O)O)c2cccc(C(=O)Nc3ccc(F)c(Cl)c3)c21

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 1/20 0.47
KMT2A Q03164 4/20 0.46
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
IDO1 P14902 1/20 0.45
MALT1 Q9UDY8 2/20 0.44
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 3/20 0.43
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 2/20 0.41
TP53 P04637 1/20 0.41
KCNJ6 P48051 1/20 0.41
KCNJ5 P48544 1/20 0.41
KCNJ3 P48549 1/20 0.41
NTRK1 P04629 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973418 0.91 TP53 (0.45) KMT2ANPC1RAB9AMEN1SMN1; SMN2
SCHEMBL21189261 0.91 FADS1 (0.45) FADS1KMT2ANPC1RAB9AIDO1
SCHEMBL19974009 0.85 FADS1 (0.52) FADS1KMT2ANPC1RAB9AIDO1
SCHEMBL21189317 0.82 MEN1 (0.41) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL19973967 0.82 NPC1 (0.45) FADS1KMT2ANPC1RAB9AMALT1
SCHEMBL20509834 0.81 FADS1 (0.51) FADS1KMT2ANPC1RAB9AIDO1
SCHEMBL26597539 0.81 FADS1 (0.51) FADS1KMT2ANPC1RAB9AIDO1
SCHEMBL19973437 0.79 FADS1 (0.48) FADS1KMT2ANPC1RAB9AIDO1
SCHEMBL19973438 0.79 FADS1 (0.48) FADS1KMT2ANPC1RAB9AIDO1
SCHEMBL19973579 0.79 FADS1 (0.48) FADS1KMT2ANPC1RAB9AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US claimed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US claimed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO claimed
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS FADS1 2483/4885KMT2A 155/4885NPC1 983/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS FADS1 2483/4885KMT2A 155/4885NPC1 983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.